Until the first FDA approval of cancer immunotherapy in 1990, the foundations of cancer treatment were surgery, chemotherapy, radiation therapy, and bone marrow transplantation. For more than a decade, immunotherapy has gained worldwide acceptance as the “fifth pillar” of cancer treatment.
Immunotherapy enlists and strengthens the power of a patient’s immune system to attack and kill the cancer cells. Within the human body, T cells are a type of white blood cell that support immunity. There are 25 million to 1 billion different types of T cells within the human body. These cells fight against anything foreign that enters the human body. [Read more…]